Abbott India Limited Cash Flow Conversion Efficiency
Abbott India Limited cash flow conversion efficiency. Based on the latest financial reports, Abbott India Limited (ABBOTINDIA) has a cash flow conversion efficiency ratio of 0.130x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs5.22 Billion ≈ $56.45 Million USD) by net assets (Rs40.11 Billion ≈ $433.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Abbott India Limited (2005–2025)
Cash flow conversion efficiency of Abbott India Limited from 2005 to 2025. This chart illustrates how Abbott India Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Abbott India Limited (ABBOTINDIA) stock price for real-time trading data and today's change.
Abbott India Limited Cash Flow Conversion Ratio Explained
Abbott India Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Abbott India Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Abbott India Limited ranked by their cash flow conversion efficiency. Also see Abbott India Limited (ABBOTINDIA) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Essential Properties Realty Trust Inc
NYSE:EPRT
|
0.023x |
|
Rayonier Inc
NYSE:RYN
|
0.116x |
|
Amdocs Limited
F:AOS
|
0.064x |
|
TXNM Energy, Inc.
NYSE:TXNM
|
0.019x |
|
Sam Yang Foods
KO:003230
|
0.037x |
|
Reinet Investments S.C.A
AS:REINA
|
0.036x |
|
News Corp B
NASDAQ:NWS
|
0.024x |
|
Amneal Pharmaceuticals, Inc. Class A Common Stock
NASDAQ:AMRX
|
-0.165x |
Annual Cash Flow Conversion Efficiency for Abbott India Limited (2005–2025)
The table below shows the annual cash flow conversion efficiency of Abbott India Limited from 2005 to 2025. Review Abbott India Limited free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs42.33 Billion ≈ $457.80 Million |
Rs10.12 Billion ≈ $109.43 Million |
0.239x | -27.10% |
| 2024-03-31 | Rs36.99 Billion ≈ $400.02 Million |
Rs12.13 Billion ≈ $131.16 Million |
0.328x | +17.02% |
| 2023-03-31 | Rs31.89 Billion ≈ $344.83 Million |
Rs8.93 Billion ≈ $96.62 Million |
0.280x | -16.63% |
| 2022-03-31 | Rs28.20 Billion ≈ $304.95 Million |
Rs9.48 Billion ≈ $102.49 Million |
0.336x | +20.33% |
| 2021-03-31 | Rs26.02 Billion ≈ $281.41 Million |
Rs7.27 Billion ≈ $78.59 Million |
0.279x | +8.47% |
| 2020-03-31 | Rs24.32 Billion ≈ $262.98 Million |
Rs6.26 Billion ≈ $67.71 Million |
0.257x | +3.61% |
| 2019-03-31 | Rs20.09 Billion ≈ $217.22 Million |
Rs4.99 Billion ≈ $53.98 Million |
0.248x | +175.47% |
| 2018-03-31 | Rs16.93 Billion ≈ $183.07 Million |
Rs1.53 Billion ≈ $16.51 Million |
0.090x | -59.27% |
| 2017-03-31 | Rs13.87 Billion ≈ $149.99 Million |
Rs3.07 Billion ≈ $33.22 Million |
0.222x | +6.50% |
| 2016-03-31 | Rs11.96 Billion ≈ $129.30 Million |
Rs2.49 Billion ≈ $26.89 Million |
0.208x | -9.21% |
| 2015-03-31 | Rs9.38 Billion ≈ $101.39 Million |
Rs2.15 Billion ≈ $23.23 Million |
0.229x | +53.60% |
| 2014-03-31 | Rs8.33 Billion ≈ $90.09 Million |
Rs1.24 Billion ≈ $13.44 Million |
0.149x | -4.81% |
| 2013-03-31 | Rs6.47 Billion ≈ $69.96 Million |
Rs1.01 Billion ≈ $10.96 Million |
0.157x | +254.26% |
| 2012-03-31 | Rs5.44 Billion ≈ $58.85 Million |
Rs240.66 Million ≈ $2.60 Million |
0.044x | -70.68% |
| 2011-03-31 | Rs3.05 Billion ≈ $33.03 Million |
Rs460.64 Million ≈ $4.98 Million |
0.151x | +10.24% |
| 2010-03-31 | Rs2.72 Billion ≈ $29.37 Million |
Rs371.57 Million ≈ $4.02 Million |
0.137x | -65.29% |
| 2009-03-31 | Rs2.21 Billion ≈ $23.93 Million |
Rs872.13 Million ≈ $9.43 Million |
0.394x | +196.26% |
| 2008-03-31 | Rs2.31 Billion ≈ $24.98 Million |
Rs307.40 Million ≈ $3.32 Million |
0.133x | -19.72% |
| 2007-03-31 | Rs2.46 Billion ≈ $26.58 Million |
Rs407.40 Million ≈ $4.41 Million |
0.166x | -2.57% |
| 2006-03-31 | Rs2.16 Billion ≈ $23.41 Million |
Rs368.20 Million ≈ $3.98 Million |
0.170x | -53.15% |
| 2005-03-31 | Rs1.88 Billion ≈ $20.36 Million |
Rs683.70 Million ≈ $7.39 Million |
0.363x | -- |
About Abbott India Limited
Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It also provides anti-infectives, cardio-diabeto, GI & hepato, hormones, … Read more